Drug Metabolism Letters

Quartiles

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

Category	Year	Quartile
Biochemistry (medical)	2008	Q3
Biochemistry (medical)	2009	Q3
Biochemistry (medical)	2010	Q2
Biochemistry (medical)	2011	Q2
Biochemistry (medical)	2012	Q2
Biochemistry (medical)	2013	Q3
Biochemistry (medical)	2014	Q3
Biochemistry (medical)	2015	Q3
Biochemistry (medical)	2016	Q3
Clinical Biochemistry	2008	Q4
Clinical Biochemistry	2009	Q4
Clinical Biochemistry	2010	Q3
Clinical Biochemistry	2011	Q3
Clinical Biochemistry	2012	Q3
Clinical Biochemistry	2013	Q3
Clinical Biochemistry	2014	Q3
Clinical Biochemistry	2015	Q3
Clinical Biochemistry	2016	Q3
Pharmaceutical Science	2008	Q3
Pharmaceutical Science	2009	Q3
Pharmaceutical Science	2010	Q2
Pharmaceutical Science	2011	Q2
Pharmaceutical Science	2012	Q2
Pharmaceutical Science	2013	Q2
Pharmaceutical Science	2014	Q2
Pharmaceutical Science	2015	Q2
Pharmaceutical Science	2016	Q2
Pharmacology (medical)	2008	Q3
Pharmacology (medical)	2009	Q3
Pharmacology (medical)	2010	Q2
Pharmacology (medical)	2011	Q2
Pharmacology (medical)	2012	Q2
Pharmacology (medical)	2013	Q3
Pharmacology (medical)	2014	Q3
Pharmacology (medical)	2015	Q3
Pharmacology (medical)	2016	Q3

SJR

The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.

Year	SJR
2008	0.147
2009	0.215
2010	0.348
2011	0.391
2012	0.370
2013	0.337
2014	0.303
2015	0.305
2016	0.386

Citations per document

This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

Cites per document	Year	Value
Cites / Doc. (4 years)	2008	0.423
Cites / Doc. (4 years)	2009	0.717
Cites / Doc. (4 years)	2010	1.000
Cites / Doc. (4 years)	2011	1.225
Cites / Doc. (4 years)	2012	1.403
Cites / Doc. (4 years)	2013	1.207
Cites / Doc. (4 years)	2014	1.024
Cites / Doc. (4 years)	2015	1.150
Cites / Doc. (4 years)	2016	1.145
Cites / Doc. (3 years)	2008	0.423
Cites / Doc. (3 years)	2009	0.717
Cites / Doc. (3 years)	2010	1.000
Cites / Doc. (3 years)	2011	1.248
Cites / Doc. (3 years)	2012	1.232
Cites / Doc. (3 years)	2013	1.267
Cites / Doc. (3 years)	2014	1.077
Cites / Doc. (3 years)	2015	0.971
Cites / Doc. (3 years)	2016	1.145
Cites / Doc. (2 years)	2008	0.423
Cites / Doc. (2 years)	2009	0.717
Cites / Doc. (2 years)	2010	1.105
Cites / Doc. (2 years)	2011	1.068
Cites / Doc. (2 years)	2012	1.342
Cites / Doc. (2 years)	2013	1.197
Cites / Doc. (2 years)	2014	0.943
Cites / Doc. (2 years)	2015	0.902
Cites / Doc. (2 years)	2016	1.100

Total Cites

Self-Cites

Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

Cites	Year	Value
Self Cites	2008	1
Self Cites	2009	1
Self Cites	2010	1
Self Cites	2011	4
Self Cites	2012	4
Self Cites	2013	3
Self Cites	2014	2
Self Cites	2015	2
Self Cites	2016	4
Total Cites	2008	22
Total Cites	2009	71
Total Cites	2010	138
Total Cites	2011	151
Total Cites	2012	138
Total Cites	2013	128
Total Cites	2014	98
Total Cites	2015	67
Total Cites	2016	63

External Cites per Doc

Cites per Doc

Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.

Cites	Year	Value
External Cites per document	2008	0.404
External Cites per document	2009	0.707
External Cites per document	2010	0.993
External Cites per document	2011	1.215
External Cites per document	2012	1.196
External Cites per document	2013	1.238
External Cites per document	2014	1.055
External Cites per document	2015	0.942
External Cites per document	2016	1.073
Cites per document	2008	0.423
Cites per document	2009	0.717
Cites per document	2010	1.000
Cites per document	2011	1.248
Cites per document	2012	1.232
Cites per document	2013	1.267
Cites per document	2014	1.077
Cites per document	2015	0.971
Cites per document	2016	1.145

% International Collaboration

International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.

Year	International Collaboration
2008	27.08
2009	10.00
2010	17.14
2011	10.53
2012	31.03
2013	7.69
2014	23.53
2015	33.33
2016	11.11

Citable documents

Non-citable documents

Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.

Documents	Year	Value
Non-citable documents	2008	1
Non-citable documents	2009	2
Non-citable documents	2010	3
Non-citable documents	2011	2
Non-citable documents	2012	1
Non-citable documents	2013	1
Non-citable documents	2014	2
Non-citable documents	2015	3
Non-citable documents	2016	6
Citable documents	2008	52
Citable documents	2009	99
Citable documents	2010	138
Citable documents	2011	121
Citable documents	2012	112
Citable documents	2013	101
Citable documents	2014	91
Citable documents	2015	69
Citable documents	2016	55

Cited documents

Uncited documents

Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.

Documents	Year	Value
Uncited documents	2008	38
Uncited documents	2009	63
Uncited documents	2010	75
Uncited documents	2011	54
Uncited documents	2012	53
Uncited documents	2013	37
Uncited documents	2014	42
Uncited documents	2015	40
Uncited documents	2016	28
Cited documents	2008	15
Cited documents	2009	38
Cited documents	2010	66
Cited documents	2011	69
Cited documents	2012	60
Cited documents	2013	65
Cited documents	2014	51
Cited documents	2015	32
Cited documents	2016	33

Show this widget in your own website

Just copy the code below and paste within your html code:

Country	United Arab Emirates	22 H Index
Subject Area and Category	Biochemistry, Genetics and Molecular Biology Clinical Biochemistry Medicine Biochemistry (medical) Pharmacology (medical) Pharmacology, Toxicology and Pharmaceutics Pharmaceutical Science
Publisher	Bentham Science Publishers
Publication type	Journals
ISSN	18723128
Coverage	2007-ongoing
Scope	Drug Metabolism Letters publishes letters and research articles on major advances in all areas of drug metabolism and disposition. The emphasis is on publishing quality papers very rapidly by taking full advantage of the Internet technology both for the submission and review of manuscripts. The journal covers the following areas: In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; recent developments for the identification of drug metabolites. (source)